Mersana Shares Rise on Advances With Breast-Cancer Treatment
Mersana Shares Rise on Advances With Breast-Cancer Treatment
Jan 10, 2025
marketscreener.com
Mersana Therapeutics, Inc. publie ses résultats financiers pour le troisième trimestre et les neuf premiers mois clos le 30 septembre 2025
Mersana Therapeutics, Inc. publie ses résultats financiers pour le tro…
6 months ago
zonebourse.com
Day One Biopharmaceuticals to acquire Mersana Therapeutics
Day One Biopharmaceuticals to acquire Mersana Therapeutics
6 months ago
marketscreener.com
Biotech Stock Catapults 200% On Surprise Takeover
Biotech Stock Catapults 200% On Surprise Takeover
6 months ago
investors.com
Mersana Therapeutics, Inc.: Mersana Therapeutics Provides Business Update and Announces Second Quarter 2025 Financial Results
Mersana Therapeutics, Inc.: Mersana Therapeutics Provides B…
9 months ago
finanznachrichten.de
Mersana Therapeutics spratt opp 200 prosent
Mersana Therapeutics spratt opp 200 prosent
6 months ago
finansavisen.no
Medicenna Therapeutics Announces Key Program Updates and 2026 Outlook
Medicenna Therapeutics Announces Key Program Updates and 2026 O…
4 months ago
financialpost.com
Marea Therapeutics | LinkedIn
Nov 28, 2023
linkedin.com
Cartesian Therapeutics | LinkedIn
Aug 2, 2024
linkedin.com
1:21
Marissa Penrod, CEO/Founder of Team Joseph, highlights the impo…
186 viewsMay 16, 2025
FacebookSarepta Therapeutics
Dianthus Therapeutics, Inc. | LinkedIn
7 months ago
linkedin.com
5:19
Medicenna Therapeutics With Founder, Chairman, President & C…
May 14, 2025
MSNStockhouse
Intellia Therapeutics, Inc.: Intellia Therapeutics Announces FDA Reg…
Nov 25, 2024
finanznachrichten.de
Sarepta Therapeutics | LinkedIn
Jul 21, 2012
linkedin.com
Terray Therapeutics | LinkedIn
Feb 21, 2019
linkedin.com
Lisata Therapeutics CEO Dr David Mazzo on global product license d…
7 months ago
proactiveinvestors.com
Madrigal Pharmaceuticals | LinkedIn
Mar 4, 2015
linkedin.com
9:07
My Take on Day One's Mersana Therapeutics Acquisition
44 views6 months ago
YouTubeCorporate Decoder
9:43
mRNA-based Therapeutics - Creative Biolabs
3.1K viewsDec 24, 2021
YouTubeCreative Biolabs
26:17
Mersana Data Review for Phase 1 dose escalation of XMT-1522
117 viewsJun 5, 2018
VimeoMersana Therapeutics
Mersana Therapeutics | LinkedIn
Feb 23, 2011
linkedin.com
5:26
Mersana Therapeutics: Fleximer Polymer Conjugated Drug Technol…
3.9K viewsJul 22, 2011
YouTubemacbiocom
39:48
Mersana Therapeutics, Inc MRSN M&A Call
5 months ago
YouTubeFyfull
0:31
Our mRNA Plaform
4.9K viewsApr 19, 2023
YouTubeModerna
5:14
Mersana Therapeutics (MRSN|$44.3M) - 2025 Q3 Earning…
16 views6 months ago
YouTubeSmartStockWatch
7:55
A Biotech Buyout Mersana Financial Analysis $MRSN MRSN #MRSN #fi…
13 views6 months ago
YouTubeMarket Pulse Report
0:28
Biomarker Prioritization: Unlocking Cancer Treatments
117 views2 weeks ago
YouTubei3 Health
1:58
PRICE EXPANSION : MRSN STOCK ANALYSIS | MERSANA THERAPE…
15 views5 months ago
YouTubeSATYAJIT DASGUPTA
32:45
Mersana Therapeutics MRSN Q2 2025 Earnings Call
14 views7 months ago
YouTubeFyfull
0:13
Highest Ever Response Rate in Phase 3 Trials!
62 views1 week ago
YouTubei3 Health
See more videos
Static thumbnail place holder